Dr. Agasjtya Wisjnu Wardhana, SpPD, K-GEH, FINASIM, a Consultant in Gastroenterology and Hepatology, served as a speaker on the topic “Challenges and Strategies for Managing Gastrointestinal Diseases in the Industry 4.0 Era” during the Seminar on Planning for the Treatment of Uronephro, Hepatic, Gastrointestinal, and Diabetes Mellitus Diseases in the Industry 4.0 Era. This seminar was part of the International Healthcare Engineering Forum (INAHEF) 2024, held at SMESCO Indonesia.

INAHEF 2024, initiated by the Presidential Staff Office (KSP) and supported by the National Development Planning Agency (Bappenas), the Ministry of Health (Kemenkes), the Ministry of Home Affairs (Kemendagri), the Ministry of Industry (Kemenperin), and the National Standardization Agency (BSN), aims to address challenges and innovations in the healthcare sector. The event was organized by the Indonesian Healthcare Engineering Association (PTPI) in collaboration with industries, universities, associations, and local governments.

In his presentation, Dr. Wisjnu highlighted several gastrointestinal diseases that continue to present significant challenges, including GERD, Functional Gastrointestinal Disorders (FGIDs), Inflammatory Bowel Diseases (IBD), colon cancer, and peptic ulcers. He emphasized that technological advancements in the Industry 4.0 era provide significant opportunities to overcome these challenges by leveraging healthcare technologies that are accessible to people across Indonesia.

He further explained that diagnostic advancements for gastrointestinal disorders have progressed remarkably, transitioning from traditional methods to more technologically advanced precision medicine. This evolution has not only improved the speed and accuracy of diagnoses but has also enabled more personalized and patient-centered care. Treatments can now be tailored to individual needs, ensuring that each patient receives the most appropriate therapy based on their genetic profile, biomarkers, and other health factors.

Additionally, Dr. Wisjnu noted that diagnostic techniques in gastroenterology have advanced from traditional methods such as X-rays and CT scans to more sophisticated technologies like endoscopy, PCR, and Next-Generation Sequencing (NGS). These technologies not only improve diagnostic accuracy but also enable early detection of genetic mutations related to diseases such as hereditary colorectal cancer syndromes.

One of the key points of his presentation was the utilization of Big Data and artificial intelligence (AI) in the diagnosis and prevention of gastrointestinal diseases. Dr. Wisjnu expressed optimism that analyzing data from electronic medical records using AI-based algorithms would allow for more accurate predictions of gastro-related disease risks, enabling more proactive preventive measures, all under the supervision of healthcare professionals.

INAHEF 2024 continues to serve as an important platform for healthcare professionals, government agencies, and industries to collaborate and seek innovative solutions for improving healthcare services in Indonesia.